Compare Stocks: RNXT, MOBI, OFIX, and RCEL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MOBI Mobia Medical	$10.01 -2.3%	$11.58	$10.01 ▼ $15.29	$341.23M	N/A	163,070 shs	132,452 shs
OFIX Orthofix Medical	$8.93 +2.8%	$10.60	$8.61 ▼ $16.99	$353.97M	0.64	285,094 shs	436,084 shs
RCEL Avita Medical	$9.88 +0.2%	$7.27	$3.22 ▼ $11.39	$303.46M	2.02	350,917 shs	225,202 shs
RNXT RenovoRx	$1.76 -0.6%	$1.29	$0.70 ▼ $2.59	$79.43M	1.12	1.45 million shs	1.16 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MOBI Mobia Medical	-2.34%	-13.93%	-13.11%	-18.68%	+1,000,999,900.00%
OFIX Orthofix Medical	+2.76%	-3.88%	-14.13%	-4.08%	-37.33%
RCEL Avita Medical	+0.20%	-11.79%	+21.67%	+152.69%	+136.93%
RNXT RenovoRx	-0.56%	-26.36%	+57.14%	+108.58%	+50.43%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MOBI Mobia Medical	$10.01 -2.3%	$11.58	$10.01 ▼ $15.29	$341.23M	N/A	163,070 shs	132,452 shs
OFIX Orthofix Medical	$8.93 +2.8%	$10.60	$8.61 ▼ $16.99	$353.97M	0.64	285,094 shs	436,084 shs
RCEL Avita Medical	$9.88 +0.2%	$7.27	$3.22 ▼ $11.39	$303.46M	2.02	350,917 shs	225,202 shs
RNXT RenovoRx	$1.76 -0.6%	$1.29	$0.70 ▼ $2.59	$79.43M	1.12	1.45 million shs	1.16 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MOBI Mobia Medical	-2.34%	-13.93%	-13.11%	-18.68%	+1,000,999,900.00%
OFIX Orthofix Medical	+2.76%	-3.88%	-14.13%	-4.08%	-37.33%
RCEL Avita Medical	+0.20%	-11.79%	+21.67%	+152.69%	+136.93%
RNXT RenovoRx	-0.56%	-26.36%	+57.14%	+108.58%	+50.43%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MOBI Mobia Medical	2.57	Moderate Buy	$20.75	107.29% Upside
OFIX Orthofix Medical	2.40	Hold	$14.75	65.17% Upside
RCEL Avita Medical	2.57	Moderate Buy	$11.40	15.38% Upside
RNXT RenovoRx	2.75	Moderate Buy	$8.50	382.95% Upside

Current Analyst Ratings Breakdown

Latest RNXT, MOBI, OFIX, and RCEL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2026	RNXT RenovoRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/28/2026	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$8.00 ➝ $12.00
8/26/2026	OFIX Orthofix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/19/2026	RCEL Avita Medical	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$12.00 ➝ $14.00
8/19/2026	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $11.00
8/18/2026	RNXT RenovoRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/12/2026	MOBI Mobia Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
8/12/2026	MOBI Mobia Medical	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$15.00 ➝ $17.00
8/12/2026	MOBI Mobia Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$19.00
8/10/2026	OFIX Orthofix Medical	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$18.00 ➝ $13.00
8/7/2026	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$7.00

(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MOBI Mobia Medical	$32.04M	10.40	N/A	N/A	N/A	∞
OFIX Orthofix Medical	$833.19M	0.44	N/A	N/A	$11.30 per share	0.79
RCEL Avita Medical	$71.61M	4.25	N/A	N/A	($0.55) per share	-17.96
RNXT RenovoRx	$1.98M	40.20	N/A	N/A	$0.15 per share	11.73

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MOBI Mobia Medical	-$46.50M	-$20.18	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	-$92.19M	-$1.54	N/A	N/A	N/A	-7.41%	-14.05%	-7.17%	11/3/2026 (Estimated)
RCEL Avita Medical	-$48.59M	-$1.44	N/A	N/A	N/A	-56.96%	N/A	-78.53%	11/5/2026 (Estimated)
RNXT RenovoRx	-$11.17M	-$0.31	N/A	N/A	N/A	-621.71%	-135.11%	-101.91%	11/12/2026 (Estimated)

Latest RNXT, MOBI, OFIX, and RCEL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	RNXT RenovoRx	-$0.0725	-$0.05	+$0.0225	-$0.06	$0.70 million	$0.91 million
8/11/2026	Q2 2026	MOBI Mobia Medical	-$0.83	-$1.10	-$0.27	-$1.10	N/A	$13.51 million
8/6/2026	Q2 2026	RCEL Avita Medical	-$0.2928	-$0.25	+$0.0428	-$5.00	$20.25 million	$21.70 million
8/5/2026	Q2 2026	OFIX Orthofix Medical	-$0.4099	-$0.39	+$0.0199	-$0.39	$209.28 million	$210.93 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MOBI Mobia Medical	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A
RNXT RenovoRx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MOBI Mobia Medical	0.04	13.28	12.80
OFIX Orthofix Medical	0.55	2.84	1.67
RCEL Avita Medical	N/A	0.41	0.34
RNXT RenovoRx	N/A	5.74	5.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MOBI Mobia Medical	N/A
OFIX Orthofix Medical	89.76%
RCEL Avita Medical	27.66%
RNXT RenovoRx	3.10%

Insider Ownership

Company	Insider Ownership
MOBI Mobia Medical	N/A
OFIX Orthofix Medical	2.70%
RCEL Avita Medical	2.24%
RNXT RenovoRx	9.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MOBI Mobia Medical	N/A	33.29 million	N/A	N/A
OFIX Orthofix Medical	1,605	40.73 million	39.63 million	Optionable
RCEL Avita Medical	130	30.78 million	30.09 million	Optionable
RNXT RenovoRx	6	45.13 million	40.89 million	Not Optionable

RNXT, MOBI, OFIX, and RCEL Headlines

Recent News About These Companies

RenovoRx FY2026 EPS Boosted by Ascendiant Capital Markets

September 4, 2026 | americanbankingnews.com

RenovoRx HC Wainwright presentation to highlight RenovoCath growth and Phase III TIGeR-PaC timeline

September 2, 2026 | msn.com

RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th

September 2, 2026 | globenewswire.com

FY2026 EPS Estimate for RenovoRx Increased by Analyst

September 2, 2026 | marketbeat.com

RenovoRx, Inc. (NASDAQ:RNXT) Short Interest Up 137.8% in August

August 28, 2026 | marketbeat.com

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced ...

August 25, 2026 | finance.yahoo.com

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform's Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

August 25, 2026 | globenewswire.com

RenovoRx (NASDAQ:RNXT) Gains Attention After Compliance Update

August 21, 2026 | kalkinemedia.comK

RenovoRx regains Nasdaq compliance

August 21, 2026 | msn.com

RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

August 21, 2026 | globenewswire.com

RenovoRx Regains Nasdaq Compliance on Minimum Bid Price

August 20, 2026 | tipranks.com

RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment

August 20, 2026 | globenewswire.com

HC Wainwright Has Positive Outlook of RenovoRx Q3 Earnings

August 18, 2026 | marketbeat.com

What is HC Wainwright's Forecast for RenovoRx Q3 Earnings?

August 17, 2026 | marketbeat.com

RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers

August 16, 2026 | marketbeat.com

RenovoRx (NASDAQ:RNXT) Upgraded to "Hold" at Wall Street Zen

August 15, 2026 | marketbeat.com

RenovoRx (RNXT) Q2 2026 Earnings Call Transcript

August 12, 2026 | finance.yahoo.com

RenovoRx, Inc. (RNXT) Q2 FY2026 earnings call transcript

August 12, 2026 | finance.yahoo.com

RenovoRx, Inc. (RNXT) Reports Q2 Loss, Beats Revenue Estimates

August 12, 2026 | zacks.com

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

August 12, 2026 | markets.businessinsider.com

RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer

August 11, 2026 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

RNXT, MOBI, OFIX, and RCEL Company Descriptions

Mobia Medical NASDAQ:MOBI

$10.01 -0.24 (-2.34%)

As of 09/11/2026 04:00 PM Eastern

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.

Orthofix Medical NASDAQ:OFIX

$8.93 +0.24 (+2.76%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$8.92 -0.01 (-0.12%)

As of 09/11/2026 07:30 PM Eastern

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Avita Medical NASDAQ:RCEL

$9.88 +0.02 (+0.20%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$10.18 +0.30 (+3.04%)

As of 09/11/2026 07:54 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

RenovoRx NASDAQ:RNXT

$1.76 -0.01 (-0.56%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$1.81 +0.05 (+2.84%)

As of 09/11/2026 07:42 PM Eastern

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RNXT, MOBI, OFIX, and RCEL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RNXT, MOBI, OFIX, and RCEL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RNXT, MOBI, OFIX, and RCEL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

RNXT, MOBI, OFIX, and RCEL Company Descriptions

Mobia Medical NASDAQ:MOBI

Orthofix Medical NASDAQ:OFIX

Avita Medical NASDAQ:RCEL

RenovoRx NASDAQ:RNXT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RNXT, MOBI, OFIX, and RCEL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RNXT, MOBI, OFIX, and RCEL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RNXT, MOBI, OFIX, and RCEL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

RNXT, MOBI, OFIX, and RCEL Company Descriptions

Mobia Medical NASDAQ:MOBI

Orthofix Medical NASDAQ:OFIX

Avita Medical NASDAQ:RCEL

RenovoRx NASDAQ:RNXT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools